Elisabeth R. van Wering

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Jacques J. M. van Dongen, Taku Seriu, E. Renate Panzer-Grümayer et al. · The Lancet · 1998 · 961 citations

Medicine, Hematology, Oncology +14

Fetal origins of the <i>TEL-AML1</i> fusion gene in identical twins with leukemia

Anthony M. Ford, Caroline Bennett, Cathy M. Price et al. · Proceedings of the National Academy of Sciences · 1998 · 319 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

Gertjan J.L. Kaspers, Rob Pieters, C. H. Van Zantwijk et al. · Blood · 1997 · 271 citations · Full text

Medicine, Oncology, Pediatrics +12

Protracted and Variable Latency of Acute Lymphoblastic Leukemia AfterTEL-AML1 Gene Fusion In Utero

Joseph L. Wiemels, Anthony M. Ford, Elisabeth R. van Wering et al. · Blood · 1999 · 260 citations

Life Sciences, Genetics, Oncology +12

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)

Willem A. Kamps, Henk van den Berg, Eva van den Berg et al. · The Lancet Oncology · 2009 · 248 citations

Medicine, Oncology, Pediatrics +11